Results 61 to 70 of about 733 (138)

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

P1363: OUTCOME OF ADULT HEMATOPOIETIC TRANSPLANT RECIPIENTS AFTER ADMISSION TO INTENSIVE CARE UNIT (ICU): SINGLE CENTRE EXPERIENCE.

open access: yesHemaSphere, 2022
A. Puchol   +6 more
doaj   +1 more source

P62 | INITIAL EXPERIENCE WITH IDECABTAGENE VICLEUCEL IN PATIENTS WITH REFRACTORY MULTIPLE MYELOMA: CASE SERIES IN A TERTIARY CARE HOSPITAL

open access: yesHaematologica
Background. Idecabtagene vicleucel (ide-cel, Abecma) is the first anti-BCMA CAR-T approved for refractory multiple myeloma (MM). Although pivotal trials have demonstrated its efficacy, real-world evidence is limited, especially in newly incorporated ...
L. Piquer Monsonis   +12 more
doaj   +1 more source

PB2215: HYDROXYUREA-INDUCED CUTANEUS ADVERSE EVENTS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A SINGLE-CENTER EXPERIENCE

open access: yesHemaSphere, 2023
Amaia Lopez Peña   +12 more
doaj   +1 more source

Hemotherapy [PDF]

open access: yesTransfusion Medicine and Hemotherapy, 2006
openaire   +1 more source

PB2323: R-ESHAP VS R-ICE AS RESCUE TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE-CENTEREXPERIENCE.

open access: yesHemaSphere, 2023
Belén Pérez-Pinilla   +9 more
doaj   +1 more source

P1502: CHARACTERIZATION OF THE MUTATION PATTERN OF GENES ASSOCIATED WITH IRON OVERLOAD IN A BRAZILIAN POPULATION

open access: yesHemaSphere, 2023
Ana Carolina Toreli   +7 more
doaj   +1 more source

History of Hemotherapy at INCA

open access: yes, 2001
De forma cronológica, o artigo retrata a História da Hemoterapia no INCA.
Guadagnino, Maria da Conceição Muniz   +2 more
openaire   +1 more source

Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis

open access: yesHematology, Transfusion and Cell Therapy
Platelet refractoriness caused by alloimmunization to anti-HLA antibodies remains present in daily hemotherapy: the frequent need for platelet transfusions may influence the long-term survival of treated patients. This study aimed to perform a systematic
Luana Joana Barreto Cabral   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy